News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
201,067 Results
Type
Article (14381)
Company Profile (24)
Press Release (186661)
Multimedia
Podcasts (18)
Webinars (5)
Section
Business (54496)
Career Advice (619)
Deals (10680)
Drug Delivery (34)
Drug Development (29673)
Employer Resources (70)
FDA (5221)
Job Trends (4255)
News (101231)
Policy (8936)
Tag
2027 Pharm Country Standard (1)
Academia (1086)
Academic (1)
Accelerated approval (7)
Adcomms (9)
Allergies (53)
Alliances (15114)
ALS (61)
Alzheimer's disease (521)
Antibody-drug conjugate (ADC) (64)
Approvals (5364)
Artificial intelligence (118)
Autoimmune disease (33)
Automation (8)
Bankruptcy (74)
Best Places to Work (3370)
BIOSECURE Act (6)
Biosimilars (75)
Biotechnology (11)
Bladder cancer (45)
Brain cancer (17)
Breast cancer (191)
Cancer (1276)
Cardiovascular disease (162)
Career advice (532)
Career pathing (14)
CAR-T (76)
CDC (21)
Celiac Disease (1)
Cell therapy (193)
Cervical cancer (11)
Clinical research (26382)
Collaboration (391)
Company closure (1)
Compensation (63)
Complete response letters (9)
COVID-19 (1141)
CRISPR (21)
C-suite (220)
Cystic fibrosis (29)
Data (2117)
Denatured (9)
Depression (45)
Diabetes (200)
Diagnostics (1862)
Digital health (10)
Diversity (8)
Diversity, equity & inclusion (29)
Drug discovery (56)
Drug pricing (59)
Drug shortages (17)
Duchenne muscular dystrophy (71)
Earnings (17648)
Editorial (25)
Employer branding (5)
Employer resources (65)
Events (24344)
Executive appointments (288)
FDA (6142)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (396)
Gene editing (40)
Generative AI (13)
Gene therapy (168)
GLP-1 (362)
Government (1290)
Grass and pollen (3)
Guidances (120)
Healthcare (5675)
HIV (36)
Huntington's disease (12)
IgA nephropathy (21)
Immunology and inflammation (66)
Immuno-oncology (15)
Indications (30)
Infectious disease (1229)
Inflammatory bowel disease (66)
Inflation Reduction Act (6)
Influenza (36)
Intellectual property (31)
Interviews (105)
IPO (3966)
IRA (22)
Job creations (991)
Job search strategy (455)
JPM (16)
Kidney cancer (4)
Labor market (21)
Layoffs (109)
Leadership (17)
Legal (1957)
Liver cancer (29)
Longevity (2)
Lung cancer (137)
Lymphoma (108)
Machine learning (7)
Management (23)
Manufacturing (189)
MASH (68)
Medical device (3455)
Medtech (3474)
Mergers & acquisitions (7033)
Metabolic disorders (445)
Multiple sclerosis (75)
NASH (15)
Neurodegenerative disease (81)
Neuropsychiatric disorders (20)
Neuroscience (924)
NextGen: Class of 2026 (2040)
Non-profit (1649)
Now hiring (6)
Obesity (177)
Opinion (62)
Ovarian cancer (46)
Pain (52)
Pancreatic cancer (46)
Parkinson's disease (100)
Partnered (13)
Patents (50)
Patient recruitment (117)
Peanut (19)
People (19601)
Pharmaceutical (9)
Pharmacy benefit managers (11)
Phase 1 (5892)
Phase 2 (11273)
Phase 3 (10713)
Pipeline (1416)
Policy (104)
Postmarket research (1294)
Preclinical (2137)
Press Release (30)
Prostate cancer (85)
Psychedelics (16)
Radiopharmaceuticals (77)
Rare diseases (235)
Real estate (1517)
Recruiting (23)
Regulatory (7018)
Reports (20)
Research institute (927)
Resumes & cover letters (83)
Rett syndrome (2)
RNA editing (1)
RSV (29)
Schizophrenia (45)
Series A (81)
Series B (55)
Service/supplier (2)
Sickle cell disease (25)
Special edition (3)
Spinal muscular atrophy (68)
Sponsored (10)
Startups (1258)
Stomach cancer (5)
Supply chain (25)
Tariffs (17)
The Weekly (9)
Vaccines (388)
Venture capital (22)
Weight loss (126)
Women's health (22)
Worklife (8)
Date
Last 7 days (152)
Last 30 days (478)
Last 365 days (7646)
2026 (622)
2025 (7922)
2024 (9155)
2023 (10540)
2022 (15318)
2021 (16565)
2020 (15759)
2019 (14455)
2018 (11158)
2017 (10525)
2016 (10130)
2015 (12213)
2014 (8430)
2013 (6478)
2012 (6926)
2011 (7206)
2010 (6285)
Location
Africa (273)
Alabama (10)
Alaska (4)
Arizona (64)
Arkansas (2)
Asia (13557)
Australia (2545)
California (2329)
Canada (610)
China (358)
Colorado (77)
Connecticut (80)
Delaware (99)
Europe (45537)
Florida (358)
Georgia (112)
Idaho (15)
Illinois (250)
India (23)
Indiana (149)
Iowa (4)
Japan (178)
Kansas (40)
Kentucky (14)
Louisiana (10)
Maine (12)
Maryland (371)
Massachusetts (1671)
Michigan (52)
Minnesota (142)
Missouri (35)
Montana (6)
Nebraska (7)
Nevada (33)
New Hampshire (11)
New Jersey (823)
New Mexico (7)
New York (794)
North Carolina (339)
Northern California (1105)
Ohio (76)
Oklahoma (3)
Oregon (5)
Pennsylvania (541)
Puerto Rico (4)
Rhode Island (4)
South America (397)
South Carolina (10)
Southern California (950)
Tennessee (33)
Texas (297)
United States (8969)
Utah (58)
Virginia (77)
Washington D.C. (8)
Washington State (231)
Wisconsin (21)
Wyoming (2)
201,067 Results for "avacta group plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Avacta Announces Year-end Trading Update
January 20, 2026
·
11 min read
Press Releases
Avacta Announces Two Key Clinical Updates to its Faridoxorubicin Program
February 3, 2026
·
4 min read
Press Releases
Avacta Announces U.S. Food and Drug Administration Clearance of the Investigational New Drug (IND) Application for the Second pre|CISION® Medicine, FAP-Exatecan (AVA6103)
January 21, 2026
·
4 min read
Press Releases
Avacta presents first preclinical data from dual payload pre|CISION® medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets
October 27, 2025
·
6 min read
Press Releases
Avacta to Present First Dual Payload pre|CISION® Medicines Data at the 2025 EORTC-NCI-AACR International Conference on Molecular Targets Symposium
October 14, 2025
·
4 min read
Press Releases
Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION® Platform at the European Society of Medical Oncology Annual Congress
October 19, 2025
·
9 min read
Press Releases
Avacta Therapeutics Announces Appointments of Industry Veterans to Board of Directors
May 28, 2025
·
7 min read
Press Releases
Avacta to Present New FAP Dox (AVA6000) Data at the European Society for Medical Oncology (ESMO) Congress
July 31, 2025
·
2 min read
Press Releases
CelLBxHealth PLC Announces Board Changes
January 12, 2026
·
4 min read
Press Releases
Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development
July 2, 2025
·
3 min read
1 of 20,107
Next
